Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 14 studies | 29% ± 14% | |
eye | 8 studies | 32% ± 13% | |
lung | 8 studies | 25% ± 9% | |
pancreas | 4 studies | 57% ± 19% | |
peripheral blood | 4 studies | 17% ± 1% | |
kidney | 4 studies | 26% ± 7% | |
intestine | 4 studies | 35% ± 12% | |
lymph node | 4 studies | 19% ± 3% | |
placenta | 3 studies | 36% ± 9% | |
uterus | 3 studies | 27% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 10807.63 | 2642 / 2642 | 99% | 339.34 | 701 / 705 |
prostate | 100% | 3773.10 | 244 / 245 | 100% | 182.98 | 500 / 502 |
adrenal gland | 100% | 3204.88 | 258 / 258 | 99% | 385.51 | 227 / 230 |
thymus | 100% | 5489.53 | 652 / 653 | 98% | 308.82 | 594 / 605 |
ovary | 100% | 4332.03 | 180 / 180 | 97% | 144.77 | 419 / 430 |
kidney | 100% | 3485.43 | 89 / 89 | 91% | 112.83 | 819 / 901 |
breast | 97% | 2382.46 | 443 / 459 | 91% | 110.99 | 1015 / 1118 |
bladder | 100% | 2575.48 | 21 / 21 | 67% | 83.66 | 338 / 504 |
lung | 97% | 2005.18 | 563 / 578 | 69% | 66.13 | 794 / 1155 |
uterus | 100% | 3302.24 | 170 / 170 | 54% | 75.69 | 250 / 459 |
skin | 68% | 976.05 | 1226 / 1809 | 83% | 106.17 | 390 / 472 |
esophagus | 98% | 2412.96 | 1411 / 1445 | 31% | 22.45 | 56 / 183 |
pancreas | 33% | 391.57 | 107 / 328 | 80% | 74.52 | 142 / 178 |
intestine | 92% | 2582.52 | 893 / 966 | 19% | 13.62 | 101 / 527 |
spleen | 100% | 2809.25 | 241 / 241 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 2478.08 | 1303 / 1335 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 93% | 107.75 | 74 / 80 |
stomach | 69% | 1470.26 | 249 / 359 | 20% | 11.42 | 56 / 286 |
heart | 89% | 2390.16 | 763 / 861 | 0% | 0 | 0 / 0 |
adipose | 85% | 1380.86 | 1019 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 41% | 25.09 | 12 / 29 |
tonsil | 0% | 0 | 0 / 0 | 38% | 32.56 | 17 / 45 |
liver | 1% | 12.10 | 2 / 226 | 22% | 14.14 | 91 / 406 |
peripheral blood | 12% | 159.33 | 113 / 929 | 0% | 0 | 0 / 0 |
muscle | 0% | 3.83 | 3 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_1904428 | Biological process | negative regulation of tubulin deacetylation |
GO_0031397 | Biological process | negative regulation of protein ubiquitination |
GO_0030334 | Biological process | regulation of cell migration |
GO_0007059 | Biological process | chromosome segregation |
GO_0042127 | Biological process | regulation of cell population proliferation |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0005874 | Cellular component | microtubule |
GO_0000922 | Cellular component | spindle pole |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0043014 | Molecular function | alpha-tubulin binding |
GO_0005515 | Molecular function | protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0140678 | Molecular function | molecular function inhibitor activity |
GO_0042826 | Molecular function | histone deacetylase binding |
Gene name | BEX4 |
Protein name | Protein BEX4 (BEX1-like protein 1) (Brain-expressed X-linked protein 4) (Nerve growth factor receptor-associated protein 3) |
Synonyms | NADE3 BEXL1 |
Description | FUNCTION: May play a role in microtubule deacetylation by negatively regulating the SIRT2 deacetylase activity toward alpha-tubulin and thereby participate in the control of cell cycle progression and genomic stability . In absence of reductive stress, acts as a pseudosubstrate for the CRL2(FEM1B) complex: associates with FEM1B via zinc, thereby preventing association between FEM1B and its substrates (By similarity). . |
Accessions | ENST00000372695.6 ENST00000372691.3 Q9NWD9 |